Description
Ultrasound is becoming the preferred imaging modality for assessing fatty liver disease, liver fibrosis, and focal liver lesions because it delivers quantitative information quickly, cost-effectively, and at the point of care.
In this expert discussion, Prof. Paul Sidhu, Professor of Imaging Sciences at King's College London and Consultant Radiologist at King's College Hospital, explains how modern liver ultrasound has transformed the management of chronic liver disease.
Using the Philips EPIQ ultrasound system, Prof. Sidhu discusses key advances including:
- Liver elastography for fibrosis assessment
- Liver fat quantification for steatotic liver disease (SLD)
- Contrast-enhanced ultrasound (CEUS) for focal liver lesion characterization
- Monitoring disease progression with quantitative ultrasound
- Same-visit diagnostic pathways that may reduce the need for additional imaging
According to Prof. Sidhu, approximately 30% of the global population may be affected by fatty liver disease, making scalable and accessible imaging solutions increasingly important for clinical practice.
Watch this video to learn how ultrasound can support earlier diagnosis, longitudinal monitoring, and greater diagnostic confidence in liver disease management.